# ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/engot-cx11-keynote-a18-a-phase-iii-randomized-double-blind-study-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Domenica Lorusso,Nicoletta Colombo,Robert L. Coleman,Leslie M. Randall,Linda Duska,Yang Xiang,Kosei Hasegawa,Angélica Nogueira Rodrigues,David Cibula,Mansoor Raza Mirza,Benoît You,Ana Oaknin,Melissa Christiaens,Çağatay Taşkıran,Elena Ioana Braicu,Jacob Korach,Christian Marth,Stephen J. O’Keefe,M. Puglisi,Sandro Pignata |
| Citations | 37 |
| DOI | 10.1200/jco.2020.38.15_suppl.tps6096 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3030611069 |
| Type | conference-abstract |
| Year | 2020 |

## Paper authors

- [Angélica Nogueira Rodrigues](https://scholariq.org/researchers/angelica-nogueira-rodrigues/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.